Stonehage Fleming (UK)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-716
Closed -$24K 345
2014
Q2
$24K Sell
716
-226
-24% -$7.58K 0.01% 228
2014
Q1
$30K Buy
+942
New +$30K 0.01% 281